February 20, 2025

NY Sues Major Vape Distributors Over Youth Marketing

Attorney General Letitia James files lawsuit against 13 e-cigarette companies for allegedly targeting minors with flavored nicotine products, seeking hundreds of millions in damages and penalties.

Conexiant

February 18, 2025

FDA Clears Aptima SARS-CoV-2 Assay for High-Throughput Testing

FDA grants 510(k) clearance for Hologic’s Aptima SARS-CoV-2 assay, which uses the Panther system for high-throughput RNA detection.

Conexiant

February 12, 2025

Psychiatrist Settles False Claims, Controlled Substances Allegations

A Connecticut psychiatrist agreed to a $455K settlement after an investigation identified fraudulent Medicare claims and unsafe controlled substance prescribing practices, resulting in DEA sanctions and a 20-year exclusion from federal health programs.

Conexiant

February 10, 2025

Can Cats Transmit H5N1 to Humans?

Growing cases of domestic cats affected by bird flu, risking zoonotic transmission and public health. Vaccination, food safety, and risks related to cat behaviors are crucial.

KFF Health News

February 07, 2025

US Flu Cases Hit 15-Year Peak

U.S. influenza activity is at its highest level in at least 15 years, with significant rise in reported cases leading to numerous hospitalizations and deaths, according to the CDC.

Reuters

February 04, 2025

FDA Approves Clinical Trials for Genetically Modified Pig Kidney Transplants

FDA-cleared clinical trials will assess the safety, immunogenicity, and viability of genetically modified pig kidney transplants in patients with end-stage renal disease.

Conexiant

February 03, 2025

U.S. COVID Cases Drop, Pfizer Outlook Shifts

“I'm sort of waiting for another variant to come out of left field. But it hasn’t happened yet.”

Reuters

February 03, 2025

FDA Monthly Round-Up: Key January Updates

January's FDA approvals include therapeutic advancements across neurology, oncology, pain management, and more.

Conexiant

January 29, 2025

COVID Research: FDA Issues Warning Letter for Clinical Trial Violations

The FDA inspected a research site and found that the trial did not meet the required ethical and procedural standards.

Conexiant